Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy - Test2 - elhamkhani - TriplyDB

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

http://www.wikidata.org/entity/Q26775037

about

New Molecular Insights of Insulin in Diabetic Cardiomyopathy Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes Uric acid predicts mortality and ischaemic stroke in subjects with diastolic dysfunction: the Tromsø Study 1994-2013 Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice Diabetic cardiomyopathy: where we are and where we are going.Diabetic retinopathy is associated with diastolic dysfunction in type 2 diabetic patients with non-ischemic dilated cardiomyopathy.Association of blood glucose level and hypertension in Elderly Chinese Subjects: a community based study Loss of Nlrp3 Does Not Protect Mice from Western Diet-Induced Adipose Tissue Inflammation and Glucose Intolerance.Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award Lecture Sensory and autonomic function and structure in footpads of a diabetic mouse model.Subclinical left ventricular diastolic dysfunction and incident type 2 diabetes risk: the Korean Genome and Epidemiology Study.Mitochondrial aldehyde dehydrogenase obliterates insulin resistance-induced cardiac dysfunction through deacetylation of PGC-1α.Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin.Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model.Apigenin alleviates STZ-induced diabetic cardiomyopathy.The effects of zofenopril on cardiac function and pro-oxidative parameters in the streptozotocin-induced diabetic rat heart.Diallyl trisulfide ameliorates myocardial ischemia-reperfusion injury by reducing oxidative stress and endoplasmic reticulum stress-mediated apoptosis in type 1 diabetic rats: role of SIRT1 activation.Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes?How cardiomyocytes sense pathophysiological stresses for cardiac remodeling.Effects of Silymarin on Diabetes Mellitus Complications: A Review.Role of mineralocorticoid receptor activation in cardiac diastolic dysfunction.Obesity-induced cardiac lipid accumulation in adult mice is modulated by G protein-coupled receptor kinase 2 levels.The mTOR Signaling Pathway in Myocardial Dysfunction in Type 2 Diabetes Mellitus.Complications of Diabetes 2016 Exosomes: A Rising Star in Falling Hearts.Assessment of Diabetic Cardiomyopathy by Cardiovascular Magnetic Resonance T1 Mapping: Correlation with Left-Ventricular Diastolic Dysfunction and Diabetic Duration.The relationship between insulin sensitivity and heart rate-corrected QT interval in patients with type 2 diabetes.SIRT1 Activation by Resveratrol Alleviates Cardiac Dysfunction via Mitochondrial Regulation in Diabetic Cardiomyopathy Mice.The clock gene, brain and muscle Arnt-like 1, regulates autophagy in high glucose-induced cardiomyocyte injury.The Mitochondrial Lon Protease Is Required for Age-Specific and Sex-Specific Adaptation to Oxidative Stress.Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity.Failure of Isoflurane Cardiac Preconditioning in Obese Type 2 Diabetic Mice Involves Aberrant Regulation of MicroRNA-21, Endothelial Nitric-oxide Synthase, and Mitochondrial Complex I.Cardiac proteasome functional insufficiency plays a pathogenic role in diabetic cardiomyopathy.CCAAT/enhancer-binding protein β overexpression alleviates myocardial remodelling by regulating angiotensin-converting enzyme-2 expression in diabetes.Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain.Metabolomics reveals new metabolic perturbations in children with type 1 diabetes.Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity.Gaseous signalling molecule SO2 via Hippo‑MST pathway to improve myocardial fibrosis of diabetic rats.The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall.

P2860

Q26752678-280AF7D4-3B35-4936-B07D-1B33DBD946EF Q28395675-BA64C8BD-4055-4054-9407-2A5DD33F2195 Q33577406-8747C453-8E9B-4CD2-86C9-9E618C61DA8F Q33644666-98AE7FEC-347F-4E00-8C0D-09E26C4A4B8A Q33690717-3A1E4AFA-C6FE-4F67-9296-BB0F35C62C57 Q33882472-3B8D2178-2456-4422-9A61-3DE035467D76 Q36076636-C7EC4D94-15EE-4BD6-9C37-675A0D9E9768 Q36119524-80CB4F07-B866-4B1E-B5A6-2F636A118EA8 Q36930826-0278606F-A94E-4EEF-A0D3-16FFD69DC499 Q37609577-D784245B-C172-462E-A0B8-96A24ED59949 Q37700844-FF8E5726-5E75-45AB-B343-86F066DF3508 Q37718230-A8AA45A7-EBC0-4FE6-9AE3-372A8E2DECAA Q38374511-B281CC87-F070-4C99-B417-56991B83BA00 Q38378534-6BA17D5E-FBDA-46DF-A37E-9099EC86ADAD Q38642356-0B2A29DE-9ECF-460B-92DC-A0B954239BE5 Q38717398-57DEB4A6-F33A-4B8C-AEBF-4B7D5C963691 Q38791358-23A872F2-6D10-4A83-BBB0-91E7949AA14E Q38813231-CA227671-5574-436B-9BF0-19D4F4AD6A2C Q38947643-A577F3E7-4095-4C31-950A-30DAE761C2E4 Q38974621-8CD7CD5A-B824-4C92-AC97-C011072B4EF5 Q38998120-8536E46F-13F1-4C9A-BFDF-E2CC024B998E Q39042819-C5C2D598-65A3-4A6A-91A8-36B5F54295C3 Q39198039-D1802E2C-5FCA-4C2E-9678-7D9CCC451C56 Q39256900-8015FECC-97CD-4014-8020-8FF6B3FFEDAD Q40485268-EC8C8CB2-7EA7-4516-883F-D9C7281BE3BB Q41001027-12577154-2CEF-4669-9E46-FAF9C5950A41 Q41169113-9FAFF75D-B5F1-4B4A-993E-A07C625AAC25 Q41281402-A8ABDB71-FB0C-49B2-8427-5D8F03172F88 Q41528591-13DA5694-A47B-4A72-A5C7-2F26C378B83D Q44024892-41691FF2-204E-420E-B06A-395F63486B69 Q45986289-CC026F34-01BF-4394-8620-13A63F6D20B1 Q46185793-F2A01E21-F38E-46D5-8864-C1359E7D23FE Q46201938-98F24249-EF10-46D0-B85F-8820C8E374C1 Q47111423-E45718D6-F72C-46EE-AA42-4B38F24173B6 Q47265749-A49FA8AE-AA70-4BC9-BC03-EBFF6C560274 Q47285651-4C6CE4EA-EE32-484D-B75A-8349A6DC480E Q47396427-6F1ABB5A-35E7-4DB6-AA5E-C7067CD5736F Q47649685-859BE479-6F0A-451A-9EF0-2E6E1938FE77 Q47679777-54694B6B-9DBF-4840-BB39-442774748074 Q47788950-75CD3CDB-33A5-4772-B706-1BFA0E10F901

P2860

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

http://www.wikidata.org/entity/Q26775037

description

2016 nî lūn-bûn

@nan

2016 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մարտին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

@ast

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

@en

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

@nl

type

label

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

@ast

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

@en

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

@nl

prefLabel

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

@ast

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

@en

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

@nl

P1433

Q26775037-23D4AA63-3F2B-475B-82EA-61627474F679

P1476

Q26775037-9F680C6C-187A-45EA-A90A-10D2A0D0C601

P2093

Q26775037-6A873AC9-E996-4FAB-9827-6FF11003069D

Q26775037-B19ECEA4-1B4A-487C-86D6-D5B7A592CB74

P2860

Q26775037-00F80E8D-EE8D-4876-A99E-14444D915522

Q26775037-0540D4A8-4CED-4FE2-9125-99B6E86B9D32

Q26775037-06504761-6EAF-4DCB-BA0C-083A0FD94EC2

Q26775037-087EA3C9-3A3C-4F4A-8CE9-6F63CED7F780

Q26775037-0911402D-6A95-43F9-A312-AAAB1CA63FE6

Q26775037-0EB4ED87-C1AA-4E2E-89EF-183F0B3EB359

Q26775037-11BAF2D0-C75C-4D27-8101-A4A2A308A16D

Q26775037-15239E40-96CA-4D49-ABF0-A534C871D722

Q26775037-17AA5AF6-4F2A-4C1E-A9E9-A94D80BA2F5F

Q26775037-18212C48-B079-4D76-9A05-4AA4362D6D12

P2888

Q26775037-FDB6A07D-40E6-411B-B628-C8BB0E9E38C2

P304

Q26775037-F72F7222-B9A0-417D-BDF6-01A94F295D2E

P31

Q26775037-5EE14FCD-28D0-42E6-92C4-808DFD1E2EAA

P3181

Q26775037-6674FC0B-7F43-4C2A-B7A1-7370F980939B

P356

Q26775037-39910AE8-17ED-40CD-A595-B3226D704B61

P407

Q26775037-50624193-DD74-4AD0-838C-61B7538C950D

P433

Q26775037-4180DAE8-8F95-4075-A626-DCE7D6E20BF8

P478

Q26775037-BD092279-D66E-4E54-9353-F33D70C5A18E

P50

Q26775037-80A8E027-DF80-42EC-A77F-8948C562DE0E

P577

Q26775037-6AED756F-F4E1-465E-B45E-16915A87A09B

P6179

Q26775037-C1F1A4D5-7852-4837-AB83-FE0465A0D5DA

P698

Q26775037-11043A6E-F8A0-47D9-B9C0-AB268206655D

P921

Q26775037-78FCEF61-FD0A-49DA-88F8-7882A3FA1BE5

P932

Q26775037-A470563B-39B4-401F-AD54-EFCA841006D2

P3181

P356

NRENDO.2015.216

P1433

Nature Reviews Endocrinology

P1476

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

@en

P2093

Guanghong Jia

http://www.w3.org/2001/XMLSchema#string

James R Sowers

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA dysregulation in diabetic ischemic heart failure patients

Inflammation, immunity, and hypertensive end-organ damage

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation

Over-nutrition and metabolic cardiomyopathy

Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction

ER stress-induced cell death mechanisms

Mitochondria and mitophagy: the yin and yang of cell death control

Chaperoning to the metabolic party: The emerging therapeutic role of heat-shock proteins in obesity and type 2 diabetes

First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics

Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling

P2888

nrendo.2015.216

P304

144-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

97216

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NRENDO.2015.216

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Vincent G DeMarco

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051707210

http://www.w3.org/2001/XMLSchema#string

P698

26678809

http://www.w3.org/2001/XMLSchema#string

P921

P932

4753054

http://www.w3.org/2001/XMLSchema#string